Atara Biotherapeutics, Inc. (ATRA) stock plunged in the after-hours; here is why?
Atara Biotherapeutics, Inc. (ATRA) declined in the after-hours market after announcing that Memorial Sloan Kettering Cancer Center (MSK) notified the FDA of a patient’s death